Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.8 SEK | -1.55% | -4.87% | +11.28% |
May. 29 | Integrum Receives Market Approval for Opra®? Implant System in Israel | CI |
May. 15 | Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu | CI |
Sales 2024 * | 107M 10.17M | Sales 2025 * | 151M 14.35M | Capitalization | 937M 88.98M |
---|---|---|---|---|---|
Net income 2024 * | 4M 380K | Net income 2025 * | 15M 1.43M | EV / Sales 2024 * | 8.54 x |
Net cash position 2024 * | 22.76M 2.16M | Net cash position 2025 * | 19.81M 1.88M | EV / Sales 2025 * | 6.07 x |
P/E ratio 2024 * |
693
x | P/E ratio 2025 * |
67.4
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.7% |
1 day | -1.55% | ||
1 week | -4.87% | ||
1 month | -11.19% | ||
3 months | +5.83% | ||
6 months | +28.93% | ||
Current year | +11.28% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 97-12-31 | |
Jörgen Svanström
DFI | Director of Finance/CFO | - | 23-05-01 |
Mats Dotevall
COO | Chief Operating Officer | 62 | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-12-31 | |
Bengt Sjöholm
CHM | Chairman | 71 | 18-12-31 |
Founder | 64 | 97-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 50.8 | -1.55% | 67,551 |
24-05-30 | 51.6 | -6.86% | 191,912 |
24-05-29 | 55.4 | +1.09% | 59,338 |
24-05-28 | 54.8 | -.--% | 37,158 |
24-05-27 | 54.8 | +2.62% | 24,756 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.28% | 88.9M | |
+3.79% | 18.79B | |
+8.00% | 14.03B | |
+11.15% | 10.41B | |
-20.38% | 1.99B | |
+3.10% | 1.76B | |
+8.31% | 1.33B | |
+6.05% | 552M | |
-.--% | 421M | |
+69.47% | 196M |
- Stock Market
- Equities
- INTEG B Stock